|
|
||||||||
The Journal of Neurophysiology Vol. 86 No. 5 November 2001, pp. 2605-2615
Copyright ©2001 by the American Physiological Society
1 Subunits Form Functional
Receptors But Not Functional Synapses in Hippocampal Neurons
1Department of Pharmacology/Physiology and 2Department of Anesthesiology, University of Rochester Medical Center, Rochester, New York 14641
| |
ABSTRACT |
|---|
|
|
|---|
Cheng, Qing,
Paul M. Burkat,
John C. Kulli, and
Jay Yang.
GABAC
1 Subunits Form Functional
Receptors But Not Functional Synapses in Hippocampal Neurons.
J. Neurophysiol. 86: 2605-2615, 2001.
The ability to control the physiological and
pharmacological properties of synaptic receptors is a powerful tool for
studying neuronal function and may be of therapeutic utility. We
designed a recombinant adenovirus to deliver either a
GABAC receptor
1 subunit
or a mutant GABAA receptor
2 subunit lacking picrotoxin sensitivity
[
2(mut)] to hippocampal neurons. A green fluorescent protein
(GFP) reporter molecule was simultaneously expressed. Whole
cell patch-clamp recordings demonstrated somatic expression of both
bicuculline-resistant GABAC receptor-mediated and
picrotoxin-resistant GABAA receptor-mediated
GABA-evoked currents in
1- and
2(mut)-transduced hippocampal neurons,
respectively. GABAergic miniature inhibitory postsynaptic currents
(mIPSCs) recorded in the presence of
6-cyano-7-nitroquinoxalene-2,3-dione, Mg2+, and
TTX revealed synaptic events with monoexponential activation and
biexponential decay phases. Despite the robust expression of somatic
GABAC receptors in
1-neurons, no bicuculline-resistant mIPSCs
were observed. This suggested either a kinetic mismatch between the
relatively brief presynaptic GABA release and slow-activating
1 receptors or failure of the
1 subunit to target properly to the
subsynaptic membrane. Addition of ruthenium red, a presynaptic release
enhancer, failed to unmask GABAC
receptor-mediated mIPSCs. Short pulse (2 ms) application of 1 mM GABA
to excised outside-out patches from
1 neurons
proved that a brief GABA transient is sufficient to activate
1 receptors. The simulated-IPSC experiment strongly suggests that if postsynaptic GABAC
receptors were present, bicuculline-resistant mIPSCs would have been
observed. In contrast, in
2(mut)-transduced
neurons, picrotoxin-resistant mIPSCs were observed; they exhibited a
smaller peak amplitude and faster decay compared with control. Confocal
imaging of transduced neurons revealed
1
immunofluorescence restricted to the soma, whereas punctate
2(mut) immunofluorescence was seen throughout
the neuron, including the dendrites. Together, the electrophysiological
and imaging data show that despite robust somatic expression of the
1 subunit, the GABAC
receptor fails to be delivered to the subsynaptic target. On the other
hand, the successful incorporation of
2(mut) subunits into subsynaptic GABAA receptors
demonstrates that viral transduction is a powerful method for altering
the physiological properties of synapses.
| |
INTRODUCTION |
|---|
|
|
|---|
The physiological and
pharmacological properties of GABA receptors are largely determined by
their subunit composition. Studies in heterologous expression systems
have shown channel activation kinetics to depend on the
subunit
(Gingrich et al. 1995
; Lavoie et al.
1997
; Verdoorn et al. 1990
) and desensitization
rate to depend on the
subunit (Haas and Macdonald
1999
). Allosteric modulation by many drugs, including
benzodiazepines, anticonvulsants, alcohol, and general anesthetics, is
also subunit-dependent (see reviews by Harrison et al.
2000
; Whiting et al. 2000
). Additionally, GABA
receptor subunit composition is developmentally regulated. In
cerebellar granule cells, for example, the postnatal loss of benzodiazepine sensitivity correlates with the switch from the
1 to the
6 isoform
(Zhu et al. 1995
). Even the different complex behavioral
effects of GABA modulators such as benzodiazepines are mediated by
different
subunits (McKernan et al. 2000
;
Rudolf et al. 1999
). It seems clear that "designer"
receptors with desired properties could be engineered by controlling
subunit composition of living neurons. These receptors might be used to
correct defective inhibitory circuitry or alternatively to enhance the
responsiveness to GABA-modulatory drugs.
We have recently reported successful adenoviral-mediated transduction
of the GABAC receptor
1
subunit in hippocampal neurons (Cheng et al. 2001
).
Virally transduced neurons were identified by a coexpressed green
fluorescent protein (GFP) reporter; double immunocytochemistry proved
co-localization of the
1 protein and the
reporter; Western blot verified the expected molecular masses; and
electrophysiological and pharmacological studies under whole cell
patch-clamp confirmed the presence of functional
GABAC receptors. Moreover, in a model of neuronal
hyperexcitability induced by chronic blockade of glutamate receptors,
GABAC receptors abolished the hyperactivity and
the consequent delayed neuronal death.
Surprisingly, mIPSCs mediated by the GABAC
receptors were not observed, thus implying the failure of these
receptors to form functional synapses. There are several possible
causes for this absence of GABAC
receptor-mediated synaptic activity. First, there could be a kinetic
mismatch between the relatively brief presynaptic GABA release and the
slow GABAC receptor-mediated postsynaptic activation: the activation kinetics of GABAC
receptors are 40 times slower than GABAA
receptors (Amin and Weiss 1994
). Therefore the time
course of presynaptic GABA release may be too rapid to activate
subsynaptic GABAC receptors. Second, there could
be a general failure of virally transduced proteins to be properly targeted to subcellular sites. And third, there could be a specific failure of the
1 subunit to be targeted to the
subsynaptic membrane. Because successful definition of synaptic
properties requires control of the composition of the subsynaptic
receptor, we further investigated the reason for the lack of
GABAC receptor-mediated synaptic events.
| |
METHODS |
|---|
|
|
|---|
Hippocampal culture
One- to 2-day-old Sprague-Dawley rat pups deeply anesthetized with halothane were decapitated, and the hippocampi were dissected out in ice-cold Ca2+-Mg2+-free Hank's balanced salt solution (Gibco, Gaithersburg, MD). The tissue was enzymatically digested with papain and bovine serum albumin (1 mg/ml for each; Sigma, St. Louis, MO) for 20 min at 37°C. Cells were disaggregated by trituration and plated on Matrigel-coated 35-mm tissue culture plates (Becton Dickinson, Bedford, MA) in Neurobasal medium (Gibco) supplemented with 2 mM L-glutamine, 10% fetal calf serum (Hyclone, Logan, UT), 5% horse serum, and B-27 supplement (Gibco). After 2-3 days growth in a 95% O2-5% CO2 humidified incubator at 37°C, the dishes were treated with 10 µM cytosine arabinoside for 24 h to suppress the growth of glia. Thereafter the medium was switched to a Neurobasal containing 5% horse serum and changed every 2-4 days until used for experiments.
GABA subunit epitope-tagging, site-directed mutagenesis, and adenovirus creation
A modified pCI-neo vector with three copies of HA-epitope-tag
(YPYDVPDYA) inserted between the Mlu and Not
sites was created. pCMV5-HA3 (a gift of Dr. Bradford Berk, University
of Rochester), containing three copies of HA-epitope-tag sequence was
used as a PCR template to synthesize a short double-stranded DNA
encoding a Mlu restriction enzyme site, three copies
of HA, a stop codon, and a NotI restriction enzyme site. The
primers used were: 3HA-For (GAATTC-ACGCGTTACCCATACGATGTTCCTGAC),
3HA-Rev (GTGCGGCCGCTCACTAGCACTGAGCAGC). The HA-tagged GABA
2(mut) and
1 subunits
were created by inserting the mutant cDNA in frame into the
Mlu restriction enzyme site of the 3HA-pCI-neo vector.
Proper function of the tagged
2(mut)-HA construct was verified by transiently transfecting HEK293 cells as a
heteromeric combination with wt
1 and
2. Likewise, homomeric tagged-
1 expression and function were
confirmed. Proper expression of the HA tag was verified by
immuno-staining the transfected HEK293 cells with anti-HA antibody.
The murine
2 subunit (a gift of Dr. David
Burt, University of Maryland) was used for oligonucleotide-mediated
site-directed mutagenesis. The oligonucleotides used to replace
threonine 257 with phenylalanine were: T246F-For
(TTAGGAATTTTCACT-GTCCTAACAATGACC), T246F-Rev
(TAGGACAGTGAAAATCCTTAATGCAACCCG). The mismatch base
pairs are indicated in bold. Successful mutagenesis and absence of
unintended mutation was confirmed by automatic sequencing of the final clone.
The recombinant E1-, E3-deleted replication-deficient human adenovirus
type-5 was created through homologous recombination between the pXCR
shuttle vector and pBHG10 parent vector (Bett et al.
1994
). The shuttle vector was modified to contain two
expression cassettes, both driven by the RSV promoter followed by a
multiple cloning site and a poly-adenylation sequence. The GFP cDNA
(Clontech, Palo Alto, CA) was subcloned into the first cassette and the
human GABA
1 subunit cDNA (a gift of Dr. Gary
Cutting, Johns Hopkins University), the GABA
2(mut) subunit, or the HA-tagged subunit cDNA
into the second. Therefore the two proteins, the GFP and one or the
other of the GABA subunits, were expressed independently. The pBHG10
plasmids and the shuttle vector containing the transgene were
cotransfected into HEK293 cells using Lipofectamine Plus following the
manufacturer's recommended protocol (Gibco). Lytic plaques were
isolated and expanded, and the presence of the transgene and the
absence of E1 gene confirmed by PCR. High titer adenovirus, twice
purified by CsCl gradient centrifugation, was stored as a 10% glycerol
suspension at
80°C. The titer of each adenovirus preparation was
determined by counting GFP-positive plaques formed in a
virus-transduced confluent HEK293 monolayer overlaid with 0.5% low
melting agarose. The concentration of virus used for transduction of
cultured cells is reported as plaque forming units (pfu)/ml rather than
pfu/cell since the number of viable cells in a culture dish was
unknown. The pBHG10 and pXCR plasmids were purchased from Microbix (Toronto).
Electrophysiology
Patch electrodes were pulled from 1.2 mm OD borosilicate
capillary glass (WPI, Sarasota, FL) and fire polished. Typical
electrodes had a resistance of 5-10 M
when filled with
intracellular solutions. For voltage-clamp experiments, the
intracellular solution consisted of (in mM) 140 CsCl, 4 NaCl, 2 MgCl2, 10 K-EGTA, and 10 HEPES; for current-clamp
recordings of action potentials, 140 mM K-gluconate replaced CsCl.
Solutions were titrated to pH 7.3 with CsOH or KOH, and supplemented
with 2 mM Mg-ATP. The external solution contained (in mM) 140 NaCl, 2.8 KCl, 1 MgCl2, 3 CaCl2 10 HEPES, 10 glucose, and was titrated to pH 7.4 with NaOH. Recordings
were made using an AxoPatch 200A amplifier (Axon Instruments, Foster City, CA). A typical access resistance of ~15 M
in the whole cell
mode of patch clamp was compensated by 75%. Voltage measurement errors
due to uncompensated series resistance were <3 mV. The cell input
capacitance was approximated by directly reading off the capacitance
compensation dial of the amplifier. Recorded membrane currents were
filtered at 5 kHz, digitized using Clampex v8.0 and analyzed with
Clampfit v6.0 (Axon Instruments). A syringe pump delivered external
solutions at 15 ml/h through orifices of a
tube mounted on a
piezoelectric transducer (Burleigh Instruments, Fishers, NY). Command
steps at 120-s intervals rapidly moved the perfusion ports, exposing
the cell to eit the control or the drug solution. The perfusion device
allowed exchange of solution in ~15 ms (10-90% rise time) for the
whole cell recording configuration. All experiments were performed at
room temperature (20-25 C°). Aqueous solutions of GABA, bicuculline
methiodide, 6-cyano-7-nitroquinoxalene-2,3-dione (CNQX), and TTX, and a
DMSO solution of picrotoxin prepared as 1,000× stock were stored as
frozen aliquots at
20 Co and freshly diluted on
the day of the experiments. Drugs were purchased from Sigma Chemicals.
The natural inhibitory postsynaptic current (IPSC) was approximated by
a 2-ms pulse of 1 mM GABA applied to an excised outside-out patch
(i.e., simulated-IPSC). The experiments were performed essentially as
described above for whole cell patch clamp but with a different drug
application device (Polytec Optronics, Costa Mesa, CA). Furthermore the
septum of the
tube was carefully etched to a minimal thickness with
hydrofluoric acid to reduce flow turbulence. With this drug applicator,
a 10-90% rise time of < 150 µs was attained at the open tip of the
recording pipette. Bicuculline was preapplied prior to GABA application
for the simulated-IPSC experiment because of potential kinetic
competition between the antagonist and the agonist at this time resolution.
Mini analysis
Miniature GABA-mediated synaptic events were recorded from
neurons held at
60 mV in the presence of 10 µM CNQX and 2.8 mM Mg2+ to block glutamatergic currents and 1 µM
TTX to block action-potential-dependent synaptic events. Continuous
data were stored on VHS tape and digitized off-line with a
DigiData-1200A A/D converter controlled with Clampex V8.0 (Axon
Instruments). Data were sampled every 0.2 ms and filtered at 2 kHz.
Miniature events were analyzed using Minianalysis (Synaptosoft, Leonia,
NJ). The program finds a local minimum (since the events are downward
going) within a data window. The peak amplitude is calculated by taking
the amplitude at the local minimum minus the average baseline current
level at the beginning of the data window. Because the peak-to-peak
noise level of the data was typically <8 pA, the peak amplitude
threshold of detection was set at 10 pA. Events were further selected
by a rise time criterion of <5 ms to assure analysis of events only
originating from proximal release sites with minimal cable distortion.
We routinely scrolled through the detected events and visually rejected
any compound events or spuriously detected events. The events were
selected for exponential fitting only if no other events occurred
within 200 ms of the peak. Decay time constants were calculated by
fitting a biexponential function. Rise times were estimated as the time required for the current to reach 10-90% of the baseline-to-peak amplitude. Kolmogorov-Smirnov two-sample test (DeGroot
1975
) was used for comparing two cumulative frequency
distributions of event amplitudes or decay time constants and the
Student t-test for comparison of means. Significance was set
at P < 0.001 for the Kolmogorov-Smirnov test and
P < 0.05 for the Student t-test since the
former statistical test appeared more sensitive to noise in the data
requiring a more stringent statistical criterion for defining
significance. Values are noted as means ± SE.
Immunocytochemistry and confocal microscope imaging
Cells grown on glass coverslips were fixed in 4%
paraformaldelyde in 0.1 M phosphate buffer for 10 min and permeabilized
in phosphate-buffered saline containing 0.2% Triton X-100 (PBST). The
cells were blocked in PBST with 10% serum for 10 min, and all
subsequent reactions were carried out in PBST with 2% serum. Primary
antibodies used for immunostaining were as follows: mouse anti-HA
(Babco, Richmond, CA, 1:500), rabbit anti-synaptophysin (Zymed, South
San Francisco, CA, 1:500), mouse anti-MAP1B (Sigma, 1:1000), mouse
anti-GABAA
2/3
(Chemicon, 1:500), mouse anti-GFP (Boehringer Mannheim, Indianapolis,
IN, 1:200). Fluorescent secondary antibodies were all obtained from
Jackson Immunoresearch Laboratory (West Grove, PA) and used at 1:500.
The digital images were acquired on a Leica TCS NT confocal microscope using the TCS-NT software (Leica, Deerfield, IL). A ×63, 1.32 NA, oil-immersion objective lens was used to visualize individual cells and neurites. The GFP (488 nm) and rhodamine (543 nm) laser gain was set at 70 and 90%, respectively, with the pinhole aperture set at 0.70-1.2 µm. Optical serial sections (z series) of 0.2-0.3 µm were taken through the cells where each planar image was an accumulation of eight time scans, and 12 to 15 planar images were reconstructed to yield the final projection images.
| |
RESULTS |
|---|
|
|
|---|
Expression of functional GABAC receptors and picrotoxin-resistant GABAA receptors
Recombinant adenoviruses were constructed to deliver a GFP
reporter molecule and either a GABAC
1 subunit or a GABAA
receptor
2 subunit with a picrotoxin
resistance mutation [
2(mut)]. We also
constructed a control virus, Ad(GFP), designed solely to express the
GFP reporter protein. In transduced hippocampal neurons, GFP
fluorescence could be detected in the somata after 24 h and in
neurites after 2-6 days as reported previously (Cheng et al. 2001
). At higher viral titers, more neurons exhibited GFP
fluorescence; however, nonneuronal cells were also transduced and gross
morphological abnormalities (such as swelling of the
neurons and stunned neurite outgrowth) occurred. Because a viral titer
of 1-5 × 105 pfu/35 mm dish had no
apparent effect on the neuronal morphology while transducing
~10-15% of the neurons, this titer was used in all subsequent
experiments. Neurons transduced with the adenovirus Ad(GFP),
Ad(
1/GFP), or
Ad(
2(mut)/GFP) are referred to as GFP,
1/GFP, or
2(mut)/GFP neurons.
To confirm the functional expression of the
1
and
2(mut) receptor subunits, the
electrophysiological properties of GFP,
1/GFP,
and
2(mut)/GFP neurons were examined with
whole cell patch clamp. In all neurons examined, GABA (30 µM),
applied to transduced neurons by a rapid perfusion device (Fig.
1, left), evoked an
inward-going current, consistent with activation of endogenous
GABAA receptors. In GFP neurons, co-applications
of either bicuculline, a GABAA receptor
antagonist, or picrotoxin, a nonspecific chloride ionophore blocker,
almost completely inhibited the GABA-evoked current (Fig. 1,
top).
|
In contrast, 20/22 fluorescent
1/GFP
neurons, after GABAA receptor blockade by
bicuculline (Fig. 1, middle, center), continued to
demonstrate GABA-evoked current, but reduced 60-70% in amplitude and
with the slower activation, desensitization and deactivation kinetics
typical of GABAC receptors (which are not
affected by bicuculline). Picrotoxin completely inhibited current in
all
1/GFP neurons (Fig. 1, middle,
right). The GABAC receptor appears to have
been successfully expressed.
2(mut)/GFP-neurons, showed the opposite
pattern. GABA-evoked current was nearly completely inhibited by
bicuculline (Fig. 1, bottom, center), but only partially
inhibited by 100 µM picrotoxin (38 ± 12% of control,
n = 8; Fig. 1, bottom, right). The
picrotoxin-resistant component had the same kinetics as the control
current. This implies that the
2(mut) subunit,
sensitive to bicuculline but resistant to picrotoxin, has been properly
incorporated into the GABAA receptors of the
2(mut)/GFP neurons.
Absence of bicuculline-resistant GABAC receptor-mediated mIPSCs
We next examined whether the virally transduced
GABAC receptors were forming functional synapses
by searching for GABAC-receptor-mediated IPSCs.
To reduce competing signals, we blocked glutamatergic receptors with
CNQX and action potentials with Mg2+ and TTX. In
GFP neurons held at
60 mV, inward-going mIPSCs were readily observed.
The frequency of mIPSCs ranged from 0.5 to 4.6 Hz, with a mean
amplitude of 41.8 ± 1.3 pA (Fig. 2,
A and D-F). Multiexponential fits to the events
revealed a fast rise time (trise = 2.9 ± 0.2 ms) and a biexponential decay time course
(
dec1 = 7.0 ± 0.3 and
dec2 = 38.2 ± 1.9 ms; all mean values,
n = 8). The GFP-neuron mIPSCs were reversibly blocked
by bicuculline (10 µM), suggesting that these events were mediated by
subsynaptic GABAA receptors exclusively.
|
In
1/GFP neurons, mIPSCs recorded in
control solution (without bicuculline) were quantitatively
indistinguishable from those obtained in control GFP neurons (Fig. 2,
B and D-F; 37.9 ± 1.5 pA,
rise = 3.2 ± 0.3 ms,
dec1= 6.5 ± 0.3, and
dec2 = 33.8 ± 1.4 ms, all mean values,
n = 10, P > 0.5 by 2-sample Student's t-test and no difference in cumulative event distribution by
Kolmogorov-Smirnov 2-sample test). Thus neither Ad(GFP) nor
Ad(
1/GFP) viral infection affected GABAergic
mIPSCs (see Table 1); both presynaptic
GABA release and postsynaptic GABAA receptors
were seemingly unchanged. When bicuculline (10 µM), which does not
block GABAC receptors, was added to the
1/GFP neurons, the mIPSCs completely
disappeared. Thus no functional subsynaptic GABAC
receptors could be identified (despite robust expression of this
receptor on the cell soma in n = 24 neurons from 8 separate transductions).
|
Ruthenium red fails to unmask bicuculline resistant receptor-mediated mIPSCs
In an attempt to reduce a possible presynaptic-postsynaptic
kinetic match, we enhanced presynaptic release of GABA. Ruthenium red
(RR) has been proposed to increase quantal transmitter release through
calcium-independent direct binding to the presynaptic membrane
(Trudeau et al. 1996
) and has been shown to increase the
frequency of mIPSCs in neonatal rat hippocampal neurons
(Sciancalepore et al. 1998
). We reasoned that if kinetic
mismatch prevented activation of subsynaptic
GABAC receptors, RR enhancement of the
presynaptic GABA release might reveal GABAC
receptor-mediated bicuculline-resistant mIPSCs.
Application of 10 µM RR to both GFP and
1/GFP neurons markedly increased the frequency
of GABAergic mIPSCs (Fig. 3, a
mean increase of 151%, range 127-204%, and 139%, range 134-144%,
for GFP and
1-GFP neurons, respectively). The effect of RR was rapid in onset, and the increased mIPSC frequency became stable within 5 min
of RR application. The amplitude, rise time, and decay constants of the
observed mIPSCs did not change in the presence of RR in either GFP or
1/GFP neurons (data not shown) in agreement
with an earlier observation on nontransduced hippocampal neurons
(Sciancalepore et al. 1998
). Notably, because
co-application of bicuculline in the presence of RR still completely
blocked mIPSCs in
1/GFP neurons, RR did not
uncover evidence for functional GABAC synapses
(Fig. 4).
|
|
Simulated IPSC predicts a readily observable GABAC receptor-mediated synaptic current
Because the precise effect of RR on presynaptic release is unknown, lack of bicuculline-resistant mIPSCs after RR cannot completely eliminate the possibility of a presynaptic/postsynaptic kinetic mismatch. Therefore by using ultra-rapid perfusion of excised outside-out patches to simulate synaptic GABA transients, we directly determined whether a brief GABA pulse could activate virally introduced GABAC receptors.
In excised patches from GFP-neurons, the current evoked by a pulse of
GABA application (2 ms, 1 mM) showed a rapid rate of rise followed by a
biexponential decay time course, with kinetic parameters in agreement
with a prior report using hippocampal neurons (Jones and
Westbrook 1995
). This simulated IPSC was blocked by
bicuculline, consistent with GABAA receptor
mediation (Fig. 4A).
In patches from
1/GFP neurons, the same GABA
pulse evoked a two-component response: a bicuculline-sensitive rapid
phase, identical to the GFP-neuron response, followed by a
bicuculline-resistant slow phase (Fig. 4B). These kinetic
and pharmacological properties are consistent with simulated IPSCs
mediated by GABAA and GABAC receptors successively. The fast phase was selectively blocked by
bicuculline while the isolated slow phase remained intact. The time
course of the GABAC receptor-mediated current
could be simulated with a kinetic model previously described for this
receptor (Chang and Weiss 1999
) with a modification to
include a blocked state distal to the open state (data not shown). Thus
despite slow activation, a short GABA transient is sufficient to
activate, with characteristic time course and pharmacology, virally
introduced GABAC receptors.
PTX-resistant mIPSCs after viral-transduction with
GABAA
2(mut) subunit
To rule out a general mistargeting of most or all virally
transduced proteins, we transduced neurons with a
GABAA
2 subunit containing a Thr257Phe point mutation. This point mutant, when incorporated with
1 and
2 subunits into a heteromeric
GABAA receptor, has been previously shown to
confer picrotoxin resistance (Gurley et al. 1995
). If
the
2(mut) subunit targets correctly, synapses
incorporating it should be identified through the presence of
PTXN-resistant mIPSCs.
Two days after viral transduction, bicuculline-sensitive,
PTXN-resistant mIPSCs were observed in 11 of 12
2(mut)/GFP neurons recorded (Fig.
5A). The mIPSC frequency in
the presence of PTXN was only ~10% of control, suggesting that the
2(mut) subunit was incorporated into a small
proportion of active synapses. Furthermore, in the presence of PTXN,
the mIPSC amplitude distribution was shifted with a significant
decrease in the mean event amplitude (36.8 ± 1.0 vs. 26.0 ± 1.8 pA, P < 0.01, n = 8). Both the
fast and slow mean mIPSC decay time constants also decreased from
dec1 = 5.3 ± 0.3 to 3.3 ± 0.3 ms
and
dec2 = 26.8 ± 1.5 to 17.0 ± 1.5 ms (P < 0.01, n = 8 for both) with
the addition of PTXN (Fig. 5, D-F). This conclusion was
supported by comparisons of the cumulative event distributions by the
Kolmogorov-Smirnov two-sample test. The percentage of fast-to-slow
components remained unchanged.
|
The existence of PTXN-resistant mIPSCs after
2(mut)/GFP-transduction indicates GABA
receptor subunit targeting to the subsynaptic membrane may be highly
specific in nature, and it shows that the viral transduction process
per se does not hinder subcellular targeting.
2(mut) subunit colocalizes with presynaptic markers;
the
1 subunit does not
It is possible that the
1 subunits are
correctly targeted to the subsynaptic region but are nevertheless
nonfunctional. To directly determine through immunohistochemical means
the subcellular locations of the virally transduced subunits and to
distinguish them from the endogenous
2
subunits, we created a virus expressing HA-epitope-tagged
2(mut) and
1
subunits. Although no endogenous
1 proteins
exist in hippocampal neurons, epitope-tagging this subunit allowed
detection of both subunits with the same anti-HA antibody.
Confocal imaging of endogenous
2/
3 subunits revealed
punctate immunoreactivity with 20-30% overlap with
synaptophysin-immunoreactivity (Fig.
6A). This was expected because
not all synaptic GABAA receptors contain these
subunits and the nonspecific presynaptic marker synaptophysin marks all
synapses, including glutamatergic synapses. Examination of
2(mut)/GFP-neurons 2 days after viral
transduction revealed strong HA immunoreactivity in the cell bodies and
bright punctate signals distributed along the neurites (Fig.
6B). When compared with the same cell probed with the
synaptophysin, the signal overlap was greater. Similarly, the HA
hot-spots correlated well with the specific presynaptic GABAergic
marker GAD (data not shown). It seems clear that
the
2(mut) subunits localize to the subsynaptic
receptors.
|
In contrast, HA-immunoreactive
1/GFP neurons
were found largely in the cell soma and did not overlay with the
synaptophysin signal (Fig. 6C). The
1 subunit, which is not expressed in native hippocampal neurons, may possess different targeting machinery from
other GABA receptor subunits. HA immunoreactivity was not seen in
nontransduced GFP-negative neurons from the same culture dish. A
Western blot with tagged subunits of the expected molecular mass showed
that the HA signal corresponds to the epitope-tagged receptor (data not
shown). Thus the immunohistochemical data supports proper subsynaptic
targeting of
2(mut) subunits but not of
1.
The microtubule-associated protein MAP1B has recently been shown to
influence the clustering of exogenously expressed
1 subunits. MAP1B immuno-staining of the
neuron culture reveals robust expression of this protein (Fig.
6D), confirming an earlier report (Sato-Yoshitake et
al. 1989
) and ruling out deficiency of MAP1B as the cause of mistargeting of the
1 subunits.
| |
DISCUSSION |
|---|
|
|
|---|
Viral transduction of hippocampal neurons with
1 subunits results in the formation of
functional GABAC receptors on the neuronal soma,
but the receptors fail to be targeted to the subsynaptic membrane and
therefore fail to be incorporated into functional synapses. Identical
transduction of the same neurons with the picrotoxin-resistant
2 subunit mutant results in incorporation of
this subunit into functional picrotoxin-resistant
GABAA receptors. We base this conclusion on
several pieces of evidence: first, in
1/GFP
neurons, a bicuculline-resistant GABAC
receptor-mediated current was clearly present in whole cell recordings,
but no bicuculline-resistant mIPSCs were observed even in the presence
of the increased transmitter release caused by ruthenium red. Second,
in
2(mut)/GFP neurons, both
picrotoxin-resistant whole cell currents and picrotoxin-resistant mIPSCs were observed. Third, brief pulses of GABA to excised, outside-out membrane patches from
1/GFP
neurons revealed clearly discernible GABAA and
GABAC receptor-mediated current components, suggesting GABAC receptors, if functionally
present, should produce synaptic events. And fourth, epitope-tagged
2(mut) subunits colocalized in neurites with
synaptic components; epitope-tagged
1 subunits did not.
Subsynaptic targeting of GABA receptors
Synaptic transmission mediated by GABAC
receptors is present in retinal bipolar cells of salamander
(Lukasiewicz and Shields 1998
) and rat (Euler and
Wassle 1998
). Immunohistochemical studies demonstrate punctate
1 immunoreactivity clusters in the retina (Enz et al. 1996
) localized to axon terminals of rod and
cone bipolar cells. Furthermore, there is no colocalization of
1 immunoreactivity with
GABAA or glycine receptor immunoreactivity,
suggesting no coassembly of
1 with the various
GABAA subunits (Enz et al. 1996
; Koulen et al. 1998
). Thus
1
subunits are independently targeted to the subsynaptic membrane in the
retina. Study of the relative current contributions
GABAA and GABAC receptors
in cone cells indicates that the ratio between these two receptors
varies depending on cell morphology (Euler and Wassle
1998
), in turn implying specific receptor targeting mechanisms.
Recent studies have begun to elucidate the mechanisms regulating
GABAA receptor subcellular trafficking (reviewed
in Barnes 2000
). The current view suggests a multilevel
regulation beginning with receptor oligomerization followed by surface
clustering. Subsequent targeting of the assembled oligomers to the
membrane surface is relatively inefficient in nonneuronal baby hamster kidney cells (Gorrie et al. 1997
) compared with neurons,
where 85-90% of
1
oligomers have a surface localization
(Calkin and Barnes 1994
). In our experiments, both
functional GABAC and
2(mut)-containing GABAA
receptors were abundantly expressed on the neuronal soma, confirming
successful subunit oligomerization and somatic membrane surface
targeting. Any difference between processing of the two receptors
appears to involve the finer regulation of receptor targeting to the
somatic or the subsynaptic membrane.
An early study using polarized Madin-Darby canine kidney (MDCK) cells
indicated that the GABAA subunit itself contains
the subcellular targeting information (Perez-Valazquez and
Angelides 1993
). This observation was recently confirmed by
Connolly et al. (1996)
. Again in MDCK cells,
GABAA receptors incorporating
1
2 or
1
3 complexes targeted
to the basolateral membrane, while
1
1-containing
receptors showed a nonpolarized distribution.
subunits probably
also contain synaptic targeting information.
5-containing GABAA
receptors are mainly found on somatic and dendritic portions of
hippocampal pyramidal neurons membranes, while
2 subunits are localized to the axon initial
segment (Nusser et al. 1996
).
If the
1 subunits follow this pattern, the
full-length protein, sufficient for proper targeting in retinal
neurons, should contain the subcellular targeting information. Either
this is not the case or, alternatively, the translocation machinery of the hippocampal neurons fails to recognize the
1 subunit. As with GABAA
subunits,
1 targeting appears to involve
interactions with cytoskeletal proteins. A yeast two-hybrid screening
demonstrated specific
1 subunit binding to the
cytoskeletal protein MAP1B (Hanley et al. 1999
); MAP1B
does not bind GABAA subunits or
2 subunits. Co-immunoprecipitation experiments
suggest that MAP1B serves as a linker protein between
1 and the cytoskeleton through its
actin/tubulin binding domain. Coexpression of MAP1B with
1 in COS cells results in a more punctate
surface localization of the
1 protein
(Hanley et al. 1999
). The
1-MAP1B interaction does more that simple
receptor localization; in retinal bipolar cells, disruption of the
interaction increases the sensitivity to GABA (Billups et al.
2000
). The GABA receptor-associated protein (GABARap) has also
been proposed to assemble neurotransmitter receptors through
interaction with the cytoskeleton, and GABAA receptor aggregation by GABARap has a similar functional consequence (Chen et al. 2000
). MAP1B is abundantly expressed within
the brain, particularly in developing neurons (Sato-Yoshitake et
al. 1989
). If it provides the subcellular targeting mechanism
for
1 subunits, then the virally transduced
1 subunits should target properly. However,
the presence of MAP1B in hippocampal neurons in itself was insufficient
for proper subsynaptic targeting of the
1
subunit protein.
Three possible explanations for the failure of
GABAC receptor targeting are suggested by the
literature. First, hippocampal neurons may lack a yet-unidentified
protein necessary for subsynaptic targeting of
1. Second, the native
GABAC receptor may be composed of more than
1 subunits. Third, there may have been
inadequate posttranslational modification (e.g., phosphorylation) of
the targeting machinery. The first possibility derives from recent data
on
2 subunit knock-out mice. Cortical neurons
from these mice show loss of the synaptic clustering molecule gephyrin
and of synaptic function (Essrich et al. 1998
). The
2 subunit and gephyrin are critical for
postsynaptic clustering of GABAA receptors. Synaptic targeting is suggested to be a two-step process: the
and
subunits determine extrasynaptic versus synaptic destination and
the other subunits of the oligomeric receptor determine the finer
segregation (Essrich et al. 1998
). However, because
gephyrin is present in both the retina (Sassoe-Pognetto et al.
1995
) and the hippocampus (Craig et al. 1996
),
it is unlikely to be the putative
1 targeting
protein. Whether gephyrin influences synaptic localization of the
GABAC receptors in the retina has not been reported.
The second possibility is that in vivo GABAC
receptors are heteroligomers between
1 and
another yet-unidentified subunit. This unknown partner could carry the
synaptic targeting information, and its absence would render our
homoligomeric
1 receptors incapable of proper
targeting in the hippocampus. In fact, molecular cloning has identified
three GABAC receptor-forming subunits,
1,
2, and
3 (reviewed in Bormann 2000
).
Reverse transcription PCR revealed both
1- and
2-mRNA in rod bipolar cells and in all brain
regions, although with the highest level of expression in rod bipolar
cells (Boue-Grabot et al. 1998
). Heteromeric assembly of
different
-subunits resulting in receptors with novel kinetic and
pharmacological properties does occur (Enz and Cutting
1999
). Thus the possibility that correct targeting of the
GABAC receptor requires a heterologous assembly
1 and non-
1 subunits
cannot be ruled out.
The third explanation is that the components necessary for proper
1-subunit targeting were present but somehow
not functional in hippocampal neurons. For example, the yeast
two-hybrid study clearly demonstrated interaction between
1 and MAP1B. Whether this interaction is
between native or phosphorylated proteins is not known. In neurons,
phosphorylated MAP1B predominates in the axons and nonphosphorylated
MAP1B in the cell body and dendrites (Sato-Yoshitake et al.
1989
). Our anti-MAP1B immunohistochemistry documented the
presence of MAP1B in hippocampal neurons and glial cells (Fig.
6D), but its phosphorylation status is unknown.
Virally transduced GABAA receptor
-subunit
coassembles with endogenous subunits
In contrast to the failure of
1 subunits
to form subsynaptic GABAC receptors, virally
transduced GABAA receptor
subunits properly
oligomerized and formed functional subsynaptic
GABAA receptors. This conclusion is supported by
the emergence of PTXN-resistant mIPSC and immunohistochemical
localization of the epitope-tagged
-subunit in the dendrites. In
fact, coassembly of the
subunit with other subunits is probably
necessary for the proper subsynaptic targeting of the oligomeric
receptor. However, the virally overexpressed
-subunit targeting may
not be as stringent as under a more physiological condition indicated
by the high degree of overlap between HA- and
synaptophysin-immunoreactivity in
2(mut)-HA
neurons (Fig. 6B). Greater targeting fidelity might be
restored by a controlled expression of the
2
subunit through promoter regulation and a titrated expression of the
subunit protein. In addition, we cannot specify the subunit composition
of the
2(mut)-containing receptors other than
to say that at least one
2(mut) was
incorporated into each functional receptor with the PTXN-resistant
phenotype. In vivo, 50% of receptor pentamers contain two different
-subunits (Li and DeBlas 1997
). Creation of tandem
subunits would eliminate this ambiguity and allow for more precise
control of the GABAA receptor subunit composition.
Adenovirus-mediated GABA receptor engineering
Adenoviral vectors can transduce hippocampal neurons both in slice
and in culture with high efficiency (Griesbaeck et al. 1997
; Wilkenmeyer et al. 1996
), and, at least in
the short term, without affecting electrical excitability or synaptic
transmission (Johns et al. 1999
; Lissen et al.
1998
; Smith et al. 1997
). However, the low
PTX-resistant mIPSC frequency observed in our study despite immunohistochemical evidence of proper subsynaptic targeting of the
2(mut) subunit may be indicative of the
first-generation adenovirus vector-induced cellular toxicity. For the
GABA receptor, Semliki forest virus (an RNA virus) co-expression of
epitope tagged-
1 and
2 subunits resulted in immunofluorescence in
the membrane surface of superior cervical ganglion neurons
(Gorrie et al. 1997
). Another recent report demonstrated
successful targeting of the
1 subunit after
Sindbis virus (an RNA virus) transduction of thalamic organotypic
culture (Okada et al. 2000
). These vectors or a
higher-generation adenovirus vector (Smith and Romero
1999
) may be required for a long-term expression of receptor
subunits without toxicity.
The possible applications of GABA receptor engineering are many. For
example, a recent study of GABAA receptor
1-subunit knock-in mice demonstrated that
sedative properties of benzodiazepines are mediated by the
1 subunit while the anxiolytic effects are mediated by the
2 subunit (McKernan et
al. 2000
; Rudolph et al. 1999
). Direct viral
overexpression of GABA receptors driven by the
2 subunit promoter in the brain might mimic
the anxiolytic effect of benzodiazepines without the sedative side
effects. Diseases of focal neuronal hyperexcitability, such as medial
temporal sclerosis, may be amenable to enhanced inhibition through a
localized overexpression of GABA receptors. At the least, the ability
to influence GABA receptor subunits in live neurons should shed light
on the functional role of GABA receptor subunit heterogeneity and
assist in tackling the fundamental questions regarding subcellular
trafficking of these receptors.
| |
ACKNOWLEDGMENTS |
|---|
The authors thank Dr. Sundeep Malik for assistance with molecular constructs and N. Ward for technical help.
This work was supported by National Institute of General Medical Sciences (NIGMS) Grants GM-57578 and GM-52325 to J. Yang. P. M. Burkat is a trainee in the Medical Scientist Training Program funded by NIGMS Grant T32 GM-07356.
| |
FOOTNOTES |
|---|
Address for reprint requests: J. Yang, Dept. of Anesthesiology, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642 (E-mail: jay_yang{at}urmc.rochester.edu).
Received 7 March 2001; accepted in final form 30 May 2001.
| |
NOTE ADDED IN PROOF |
|---|
Filippova et al. (2001)
recently reported successful
adenovirus-mediated expression of the human
1 subunit in
hippocampal neurons.
| |
REFERENCES |
|---|
|
|
|---|
1 GABA channels: activation properties and domains.
Recep Channels
2:
227-236, 1994[ISI][Medline].
subunits in rat brain.
J Neurochem
70:
899-907, 1998[ISI][Medline].
-aminobutyric acid type A (GABAA) receptor-associated protein (GABARap) promotes GABAA receptor clustering and modulates the channel kinetics.
Proc Natl Acad Sci USA
97:
11557-11562, 2000
-aminobutyric acid type A receptors is determined by receptor
subunits.
Proc Natl Acad Sci USA
93:
9899-9904, 1996
subunits in the mammalian retina.
J Neurosci
16:
4479-4490, 1996
subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct properties.
Eur J Neurosci
11:
41-50, 1999[ISI][Medline].
2 subunit and gephyrin.
Nat Neurosci
1:
563-571, 1998[ISI][Medline].
1 subunit.
J Physiol
535:
145-153, 2001
-subunit isoform: implications for structure-function relations and synaptic transmission.
J Physiol (Lond)
489:
529-543, 1995[ISI][Medline].
1 and
2 subunits in both cultured neurons and fibroblasts.
J Neurosci
17:
6587-6596, 1997
,
, or
subunit of the GABAA channel that abolish block by picrotoxin.
Recept Channels
3:
13-20, 1995[ISI][Medline].
-subunits in the rat retina.
Eur J Neurosci
10:
115-127, 1998[ISI][Medline].
-subunit isoform.
Biophys J
73:
2518-2526, 1997
subunit isoforms in the same
-aminobutyric acid type A receptor.
J Biol Chem
272:
16564-16569, 1997
1 subtype.
Nat Neurosci
3:
587-592, 2000[ISI][Medline].
subunits expression with the properties of IPSCs in the developing thalamus.
J Neurosci
20:
2202-2208, 2000
-aminobutyric acid-A receptor subtypes.
Nature
401:
796-800, 1999[Medline].